Qiu, Die
Gu, Bin
Xiao, Siqun
Chai, Ze
Cai, Shunv
Xu, Pingbo
Funding for this research was provided by:
Hangzhou Institute of Medicine, Chinese Academy of Sciences. (2024ZZBS13)
Article History
Received: 21 July 2025
Accepted: 1 December 2025
First Online: 7 December 2025
Declarations
:
: This protocol was approved by the Medical Ethics Committee of Zhejiang Cancer Hospital, China (Chairperson proof: Professor Zhu Ji) (Ethical Approval Number: IRB-2024-851) on 10 September 2024. This study followed the CONSORT reporting guidelines and was performed in accordance with the Declaration of Helsinki. The study was registered with chictr.org.cn (20th September 2024, ChiCTR2400089978) and was conducted at the Zhejiang Cancer Hospital. Before participation, all the patients provided written informed consent.
: Not applicable.
: The authors declare no competing interests.